Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
See Latest ArticlesSPIRIT IV Results Reaffirm Strong Performance of Boston Scientific PROMUS and TAXUS Express Stents
Boston Scientific, 09/24/09
Boston Scientific Corporation welcomed one–year data from the SPIRIT IV clinical trial comparing the XIENCE V Everolimus–Eluting Coronary Stent System to the TAXUS Express2™ Paclitaxel–Eluting Coronary Stent System. The results support the benefits of paclitaxel–eluting stents in diabetic patients. The trial enrolled 3,690 patients, including 1,140 diabetics, the largest diabetic subset ever studied in a drug–eluting stent clinical trial.
Today in Drug Trials...keeping you current
Receive free subspecialty "5-minute updates" via email
Data Presented at San Antonio Breast Cancer Symposium Demonstrate Treatment with Denosumab is Superior to the Standard of Care
Amgen, 12/10/09
Phase I Study of Intravenous Vascular Endothelial Growth Factor Trap, Aflibercept, in Patients With Advanced Solid Tumors
Journal of Clinical Oncology, 12/10/09
Fyi from human genome sciences: gsk initiates second pivotal phase 3 trial for investigational cardiovascular medication darapladib
Human Genome Sciences, 12/10/09
Sponsor
Article Search
Sponsor
Sponsor